Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.
about
Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and OutcomesInfluence of a 10-Day Mimic of Our Ancient Lifestyle on Anthropometrics and Parameters of Metabolism and Inflammation: The "Study of Origin"Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseasesAn examination of global and regional opioid consumption trends 1980-2011.Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya.Medicalization of global health 3: the medicalization of the non-communicable diseases agenda.Trade and investment liberalization and Asia's noncommunicable disease epidemic: a synthesis of data and existing literature.National drug policy reform for noncommunicable diseases in low-resource countries: an example from BangladeshA national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon.Access to drugs for treatment of noncommunicable diseases.Assessment of a revolving drug fund for essential asthma medicines in BeninAdherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional studyImpact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis.Access to Treatment for Diabetes and Hypertension in Rural Cambodia: Performance of Existing Social Health Protection Schemes.Noncommunicable Diseases In East Africa: Assessing The Gaps In Care And Identifying Opportunities For ImprovementBarriers in household access to medicines for chronic conditions in three Latin American countries.Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.A study on the factors affecting the prescription of injection medicines in Iran: a policy making approach.Educational status-related disparities in awareness, treatment and control of cardiovascular risk factors in IndiaAccess to Medications for Cardiovascular Diseases in Low- and Middle-Income CountriesA human rights-based approach to the reimbursement of expensive medicinesInnovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?The impact of health systems on diabetes care in low and lower middle income countries.Country and regional variations in purchase prices for essential cancer medications.Diabetes in sub-Saharan Africa - from policy to practice to progress: targeting the existing gaps for future care for diabetesNon-communicable diseases and HIV care and treatment: models of integrated service delivery.Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.Global cancer disparity highlighted.Survey on the availability, price and affordability of selected essential medicines for non-communicable diseases in community pharmacies of Kathmandu valley.Regulatory and logistical issues influencing access to antineoplastic and supportive care medications for children with cancer in developing countries.Inequality in health status among older adults in Africa: the surprising impact of anti-retroviral treatment.Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities.Disparities in availability of essential medicines to treat non-communicable diseases in Uganda: A Poisson analysis using the Service Availability and Readiness Assessment.An evaluation of the 25 by 25 goal for premature cardiovascular disease mortality in Taiwan: an age-period-cohort analysis, population attributable fraction and national population-based study.Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: A qualitative investigation.Preparedness for delivering non-communicable disease services in primary care: access to medicines for diabetes and hypertension in a district in south India.Views by health professionals on the responsiveness of commune health stations regarding non-communicable diseases in urban Hanoi, Vietnam: a qualitative study.Improving health-care delivery in low-resource settings with nanotechnology: Challenges in multiple dimensions.
P2860
Q28081319-ED5A69D5-4616-446D-B0D4-38B2D7900EFAQ28829810-D2B2C5F2-909B-4BF2-92F6-F1FF82507D8AQ30061822-4DD1866D-354C-44B8-8AB1-77E11905CBD3Q30208960-099CD095-B72D-4629-B7B2-21227EF7A97FQ30379796-73878A2A-F846-422A-A5B3-8AFCD617D096Q30391670-B78E86F5-7E42-42C0-ABDF-B926A91934D2Q30850771-4EE514BA-B07A-4097-BC32-2B9CD4ED514FQ33640967-6129E659-9A60-4585-8BAD-D011D4917086Q34067638-45510588-6FEE-4005-A849-92D60C024EC2Q34450625-2011A7D0-E142-4424-9D14-9DB0597E84D5Q34916353-C7BF96F1-1823-4DC0-B355-34F3D22B96E8Q35382074-5BBABCC0-53F8-481C-BAFB-DFDFDFC6DB58Q35519010-108BAE4C-4DE1-4A5F-B957-012E0075498DQ35685827-D1803BE5-FF8B-4CE0-8548-5FBDEC50EB44Q35905686-F9EC4D37-04A8-4FBB-B494-B94174487694Q36056477-090EC766-DC55-4424-A0C7-239DFE4D3DE4Q36234808-E221FD14-CB17-429C-863F-6C9ACF6C9CEEQ36249454-20C5B814-9652-46C3-8427-EA4F15F98642Q36303856-39B1079C-9298-4BF0-B7EA-304B9A34AF49Q36712899-309CDC27-E966-4DF8-8DE6-387DC7DA5F5FQ36801042-322565E6-E92D-46CC-AF91-F1A830CDA6BDQ36936076-E4C4FAF1-7D0F-4B5F-8DC9-B0394A65A7EEQ37498178-5E0D4CDC-1768-47D4-8D0C-4D1A63E8983CQ37639855-F00F798A-D152-4E44-AAD7-022D421ADC1EQ38365643-0E69969C-868C-4994-8CED-08837FC645FDQ38610498-F10794FB-25BF-48A5-AC3B-E0B72FE26AB8Q38645193-DF62253C-83A7-401C-A506-270D1EDC4D0FQ39142434-FBD16775-678D-4378-911D-DE8BE1AF5572Q39252137-D9CB783E-7AAD-4BF5-8FCE-7FD060140B7AQ42934902-948E4A25-F59D-4687-BF00-3877BA950943Q45364531-B0B14B2F-B6C8-4687-B2B1-9C692472FBA1Q46758549-54F8BCFA-9A9A-4E6E-9377-6146BCEDB339Q46921489-FC6CF934-407C-4898-AF85-31F5648A322CQ49954874-D4E9DC87-6A93-42C6-8AB6-27FFF12EFD6CQ50107477-40EEE512-6388-457C-B585-69BCC8364803Q50315789-6A911DEA-CC0A-401A-8B85-A34D6D7BEAA8Q53423872-766B27BA-5B09-4F5F-8BC4-74DAD96D1739Q54967834-79966B16-0C11-4760-8CAB-88C00E5CFFF9Q55085861-086EACE8-F9D4-4C8E-99DE-C54A3A557CB6Q55345336-6B8D096D-70D0-4B27-8E79-EA78D93EFF3D
P2860
Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Promotion of access to essenti ...... the UN political declaration.
@en
type
label
Promotion of access to essenti ...... the UN political declaration.
@en
prefLabel
Promotion of access to essenti ...... the UN political declaration.
@en
P2093
P1433
P1476
Promotion of access to essenti ...... the UN political declaration.
@en
P2093
Faith N Mwangi-Powell
Jonathan Liberman
Lancet NCD Action Group
Rachel Kiddell-Monroe
Sandeep P Kishore
Tido von Schoen-Angerer
Veronika J Wirtz
P304
P356
10.1016/S0140-6736(12)62128-X
P407
P577
2013-02-12T00:00:00Z